Edition:
United States

Basilea Pharmaceutica AG (BSLN.S)

BSLN.S on Swiss Exchange

76.00CHF
5:44am EST
Change (% chg)

CHF0.00 (+0.00%)
Prev Close
CHF76.00
Open
CHF75.90
Day's High
CHF76.35
Day's Low
CHF75.85
Volume
11,277
Avg. Vol
54,147
52-wk High
CHF95.35
52-wk Low
CHF69.85

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-17 2 93.45 95.10 91.80 92.50
Year Ending Dec-18 2 91.25 98.10 84.40 109.85
Earnings (per share)
Year Ending Dec-17 2 -2.29 -1.83 -2.74 -2.46
Year Ending Dec-18 1 -2.59 -2.59 -2.59 -1.48
Sales and Profit Figures in Swiss Franc (CHF);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 188.50 35.37
P/E High - Last 5 Yrs. -- 275.44 45.18
P/E Low - Last 5 Yrs. -- 92.47 24.20
Beta 1.37 0.82 0.91
Price to Sales (TTM) 11.80 113.76 5.84
Price to Book (MRQ) -- 21.88 5.65
Price to Tangible Book (MRQ) -- 25.71 7.25
Price to Cash Flow (TTM) -- 102.10 24.30
% Owned Institutions -- 5.62 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg 1.21 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 97.35 46.04

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 38.49 -3.12 6.82
Sales (TTM) vs TTM 1 Yr. Ago 35.14 30.10 5.63
Sales - 5 Yr. Growth Rate -0.50 33.18 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago 31.18 -148.25 7.98
EPS (TTM) vs TTM 1 Yr. Ago 28.13 -- --
EPS - 5 Yr. Growth Rate -- 43.65 10.92
Capital Spending - 5 Yr. Growth Rate -34.31 40.96 15.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.78 1.80 2.55
Current Ratio (MRQ) 2.98 5.70 3.56
LT Debt to Equity (MRQ) -- 14.49 13.37
Total Debt to Equity (MRQ) -- 16.95 19.40
Interest Coverage (TTM) -17.38 -138.10 44.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 92.31 43.91 54.89
Gross Margin - 5 Yr. Avg. -- 55.68 52.44
EBITD Margin (TTM) -45.22 -- --
EBITD - 5 Yr. Avg -84.28 -215.89 15.52
Operating Margin (TTM) -48.03 -626.98 6.76
Operating Margin - 5 Yr. Avg. -89.66 -232.77 11.02
Pre-Tax Margin (TTM) -56.97 -597.81 7.58
Pre-Tax Margin - 5 Yr. Avg. -92.75 -233.06 11.42
Net Profit Margin (TTM) -57.44 -595.34 3.81
Net Profit Margin - 5 Yr. Avg. -93.21 -236.34 7.71
Effective Tax Rate (TTM) -- 15.36 24.25
Effective Tax Rate - 5 Yr. Avg. -- 18.92 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 318,667 21,716,698 852,152,758
Net Income/Employee (TTM) -183,042 -1,723,651 99,529,045
Receivable Turnover (TTM) 27.34 26.31 6.14
Inventory Turnover (TTM) 0.45 2.63 3.55
Asset Turnover (TTM) 0.24 0.42 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -13.74 -9.30 11.32
Return on Assets - 5 Yr. Avg. -14.90 0.22 12.29
Return on Investment (TTM) -17.70 -11.67 14.45
Return on Investment - 5 Yr. Avg. -18.35 3.35 16.09
Return on Equity (TTM) -- -36.21 16.05
Return on Equity - 5 Yr. Avg. -78.01 5.77 17.30
  1 Year 3 Year 5 Year
Sales % 25.91 16.67 -0.50
EPS (TTM) % 16.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Basilea Pharmaceutica AG

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.86 -1.63 99 96
13 Week -5.41 -8.52 99 68
26 Week -2.06 -7.23 99 62
52 Week 6.44 -8.58 99 60
YTD 3.97 -8.71 99 49
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 33.88%
# of Holders: 81
Total Shares Held: 4,022,369
3 Mo. Net Change: -530,427
# New Positions: 3
# Closed Positions: 3
# Increased Positions: 14
# Reduced Positions: 12
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.